IP Library › Granted Patent US 8,781,578
Granted Patent B2
US 8,781,578 · App. 12/616,336 · Granted Jul 15, 2014

Mass attribute detection through phrenic stimulation

Inventors: Aaron R. McCabe (Minneapolis, MN); Holly Rockweiler (Minneapolis, MN); Jacob I. Laughner (St. Louis, MO)
Assignee: Cardiac Pacemakers, Inc.
A61N1/3702
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,781,578
App. No.
12/616,336
Granted
Jul 15, 2014
Kind
B2
Abstract

According to certain examples, an implanted medical device is used to determine a mass attribute of a patient. The patient's phrenic nerve is stimulated, and the diaphragmatic response is measured by an accelerometer. The measured response is analyzed in certain embodiments to determine a mass attribute. This information can help in the diagnosis of, and efficient response to, edema.

Claims (34)

1. A system comprising:

an accelerometer configured to sense an acceleration signal indicative of a response to an electrical stimulation of a phrenic nerve of a patient;

a processing circuit in communication with the accelerometer, the processing circuit configured to:

receive information from the acceleration signal;

determine a mass attribute of the patient using the received information from the acceleration signal, the determined mass attribute comprising at least one of a mass of an upper body of the patient, a mass of a thorax of the patient, a body mass index (BMI) value, mass composition information, and a systemic mass value of the entire patient; and

provide an indication of the mass attribute to a user or process.

2. The system of claim 1 , wherein the accelerometer comprises a multi-axis accelerometer, and wherein the processing circuit is configured to use information about a directional component of the acceleration signal sensed by the multi-axis accelerometer to determine the mass attribute of the patient.

3. The system of claim 1 , wherein the processing circuit is configured to determine the mass composition information, the mass composition information comprising at least one of: a fluid component level, a fatty tissue component level, or a lean tissue component level.

4. The system of claim 1 , comprising a telemetry circuit operatively connected to the processing circuit, the telemetry circuit configured to wirelessly communicate information based on the mass attribute.

5. The system of claim 4 , further comprising an external computing interface comprising a display, wherein the external interface is configured to receive the information based on the mass attribute from the telemetry circuit and to display an indication based on the mass attribute on the display.

6. The system of claim 1 , further comprising an implantable phrenic nerve stimulation circuit configured to provide the electrical stimulation to the phrenic nerve of the patient.

7. The system of claim 6 , wherein the implantable phrenic nerve stimulation circuit is configured to be implanted in or on a heart of the patient.

8. A method performed by a medical device comprising:

electrically stimulating a phrenic nerve of a patient;

receiving an acceleration signal from an accelerometer, the acceleration signal indicative of a response in the patient to the electrical stimulation of the phrenic nerve;

determining a mass attribute of the patient based at least in part on the received acceleration signal; the mass attribute comprising at least one of a mass of an upper body of the patient, a mass of a thorax of the patient, a body mass index (BMI) value, mass composition information, and a systemic mass value of the entire patient; and

communicating an indication of the mass attribute to a user or process.

9. The method of claim 8 , wherein determining the mass attribute comprises determining an approximate composition, wherein the approximate composition comprises at least one of: a fluid component level, a fatty tissue component level, or a lean tissue component level.

10. The method of claim 8 , wherein determining the mass attribute comprises measuring a peak-to-peak amplitude of the acceleration signal.

11. The method of claim 8 , wherein determining the mass attribute comprises determining a frequency response of the acceleration signal.

12. The method of claim 8 , comprising sensing the acceleration signal, wherein sensing the acceleration signal comprises using a multi-axis accelerometer, and wherein determining the mass attribute comprises using a directional component of the sensed acceleration signal indicative of the response to the electrical stimulation of the phrenic nerve.

13. The method of claim 8 , comprising:

determining whether the mass attribute meets a specified criterion; and

generating an alert signal when the mass attribute meets the specified criterion.

14. The method of claim 8 , wherein electrically stimulating, the phrenic nerve comprises using an electrode implanted in or on a heart of the patient.

15. The method of claim 14 , further comprising selecting a pacing vector, a pulse width, and a pulse amplitude sufficient to electrically stimulate the phrenic nerve.

16. The method of claim 8 , wherein electrically stimulating the phrenic nerve comprises timing the electrical stimulation of the phrenic nerve to be provided at a specified portion of at least one of a cardiac cycle or a respiratory cycle.

17. The method of claim 8 , comprising comparing the mass attribute to the systemic mass value.

18. The method of claim 8 , wherein determining the mass attribute comprises determining the systemic mass value of the patient.

19. A system comprising:

means for electrically stimulating a phrenic nerve of a patient;

means for receiving an acceleration from an accelerometer the acceleration signal indicative of a response in the patient to the electrical stimulation of the phrenic nerve;

means for determining a mass attribute of the patient based at least in part on the received signal, the mass attribute comprising at least one of a mass of an upper body of the patient, a mass of a thorax of the patient, a body mass index (BMI) value, mass composition information, and a systemic mass value of the entire patient; and

means for communicating an indication of the mass attribute to a user or process.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2010
From: MCCABE, AARON R.; ROCKWEILER, HOLLY; LAUGHNER, JACOB I.
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 023763/0001 →
Continuity (2)
Provisional Application 61114542 · Nov 14, 2008
Related Publication 20100125306A1 · May 20, 2010